The committee would like to offer sincere thanks to Optibrium for kindly sponsoring the web hosting services.

Optibrium develops intuitive software for small molecule design, optimisation and data analysis. Their lead product, StarDrop™, is a comprehensive suite of integrated software that enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research. Cerella™, Optibrium’s proven AI, guides successful drug discovery, generating valuable insights from your data, whilst Inspyra™ combines your expert chemistry knowledge with the exploratory power of generative AI methods to create, evaluate and optimise novel compound ideas.

Optibrium was founded in 2009 in Cambridge, UK, with a US subsidiary, Optibrium Inc., in Cambridge, MA. The company works with over 180 customers and collaborators, including leading global pharma, biotech, agrochemical companies and academic groups.